Mammoth Biosciences
Renan Sper DVM, Ph.D. is a Principal Scientist at Mammoth Biosciences with a background in maternal-fetal biology and regenerative medicine. Previously, Renan held roles as a Scientist II at GenEdit and as a Research Specialist at UCSF Center for Maternal-Fetal Precision Medicine, where they co-authored research on MPS7 syndrome in mice. Renan also has experience in veterinary animal reproduction, including managing cases and conducting research projects at NC State College of Veterinary Medicine. With a Ph.D. in comparative biomedical science and a DVM in veterinary medicine, Renan brings a wealth of knowledge and experience to their current role.
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.